Lv1
24 积分 2025-04-22 加入
Targeting cancer with molecular glues
1天前
已完结
Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS
1天前
已完结
Multivalent linkers: A growing trend in antibody–drug conjugate development
2天前
已完结
Recent Trends in Peptide Drug Discovery and Development
26天前
已完结
Orthogonal Conjugation via Endoglycosidase and Microbial Transglutaminase Enables Efficient Synthesis of Dual-Payload Antibody-Drug Conjugates
4个月前
已完结
177Lu-Labeled Antibody–Drug Conjugate: A Dual-Mechanistic Treatment Modality in Solid Tumors
6个月前
已完结
The role of hydrophilic linkers in next-generation antibody-drug conjugates
6个月前
已完结
AbClick Pro H: Scavenger-Free, Traceless Lys248 Conjugation Via O -Acyl Hydroxamate Chemistry for Homogeneous Antibody–Drug Conjugates (ADCs)
6个月前
已完结
AJICAP-M: Traceless Affinity Peptide Mediated Conjugation Technology for Site-Selective Antibody–Drug Conjugate Synthesis
6个月前
已完结
Izalontamab brengitecan, an EGFR and HER3 bispecific antibody–drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China
8个月前
已完结
皖公网安备34019202002308
